TEOC Oncologia Clínica

TEOC — Título de Especialista em Oncologia Clínica (SBOC, Brazil)

Tumores GeniturinariosEnglish
Exam overview

Practice session

A 64-year-old man presents with newly diagnosed de novo high-volume metastatic hormone-sensitive prostate cancer (mHSPC) with 6 painful bone metastases and extensive retroperitoneal adenopathy. Baseline PSA is 145 ng/mL. According to the ARASENS and PEACE-1 phase III trials, what triplet systemic therapy provides the greatest overall survival benefit over androgen deprivation therapy (ADT) alone?

Loading your practice session…